20-289563-T-C
Position:
Variant summary
Our verdict is Benign. Variant got -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BS1BS2
The NM_153269.3(C20orf96):āc.183A>Gā(p.Gln61Gln) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00247 in 1,612,896 control chromosomes in the GnomAD database, including 90 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (ā ā ).
Frequency
Genomes: š 0.013 ( 37 hom., cov: 31)
Exomes š: 0.0014 ( 53 hom. )
Consequence
C20orf96
NM_153269.3 synonymous
NM_153269.3 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.148
Genes affected
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -21 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.87).
BP6
Variant 20-289563-T-C is Benign according to our data. Variant chr20-289563-T-C is described in ClinVar as [Benign]. Clinvar id is 783855.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-0.148 with no splicing effect.
BS1
Variant frequency is greater than expected in population afr. gnomad4 allele frequency = 0.0126 (1923/152254) while in subpopulation AFR AF= 0.0437 (1816/41532). AF 95% confidence interval is 0.0421. There are 37 homozygotes in gnomad4. There are 920 alleles in male gnomad4 subpopulation. Median coverage is 31. This position pass quality control queck.
BS2
High Homozygotes in GnomAd4 at 37 AR gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
C20orf96 | NM_153269.3 | c.183A>G | p.Gln61Gln | synonymous_variant | 3/11 | ENST00000360321.7 | NP_695001.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
C20orf96 | ENST00000360321.7 | c.183A>G | p.Gln61Gln | synonymous_variant | 3/11 | 1 | NM_153269.3 | ENSP00000353470.2 | ||
C20orf96 | ENST00000400269.4 | c.180A>G | p.Gln60Gln | synonymous_variant | 3/11 | 1 | ENSP00000383128.4 | |||
C20orf96 | ENST00000382369.9 | c.82+696A>G | intron_variant | 5 | ENSP00000371806.5 |
Frequencies
GnomAD3 genomes AF: 0.0126 AC: 1920AN: 152136Hom.: 36 Cov.: 31
GnomAD3 genomes
AF:
AC:
1920
AN:
152136
Hom.:
Cov.:
31
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00332 AC: 836AN: 251484Hom.: 16 AF XY: 0.00241 AC XY: 328AN XY: 135916
GnomAD3 exomes
AF:
AC:
836
AN:
251484
Hom.:
AF XY:
AC XY:
328
AN XY:
135916
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00141 AC: 2056AN: 1460642Hom.: 53 Cov.: 30 AF XY: 0.00122 AC XY: 890AN XY: 726712
GnomAD4 exome
AF:
AC:
2056
AN:
1460642
Hom.:
Cov.:
30
AF XY:
AC XY:
890
AN XY:
726712
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0126 AC: 1923AN: 152254Hom.: 37 Cov.: 31 AF XY: 0.0124 AC XY: 920AN XY: 74450
GnomAD4 genome
AF:
AC:
1923
AN:
152254
Hom.:
Cov.:
31
AF XY:
AC XY:
920
AN XY:
74450
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
8
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Apr 10, 2018 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
RBP_binding_hub_radar
RBP_regulation_power_radar
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at